← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
51	51 Pluri PLUR $11.9M	52	-1	-2%	$32.7M
52	52 DELISTED Poseida Therapeutics, Inc. Common Stock PSTX	52	+52	–	$217M
53	LOGC 53 DELISTED LogicBio Therapeutics, Inc. Common Stock LOGC	51	+8	+19%	$97.6M
54	54 Mesoblast MESO $1.81B	51	+8	+19%	$61.1M
55	55 Legend Biotech LEGN $3.85B	50	-27	-35%	$753M
56	SIOX 56 DELISTED Sio Gene Therapies Inc. Common Stock SIOX	50	+10	+25%	$52.7M
57	57 Autolus Therapeutics AUTL $458M	46	-4	-8%	$143M
58	58 Taysha Gene Therapies TSHA $1.22B	46	+46	–	$367M
59	59 DELISTED Carisma Therapeutics CARM	45	+5	+13%	$32.3M
60	60 Immatics IMTX $1.09B	44	+12	+38%	$199M
61	PTE 61 DELISTED PolarityTE, Inc. Common Stock PTE	41	-11	-21%	$6.95M
62	62 Lunai Bioworks LNAI $3.74M	39	+6	+18%	$8.54M
63	63 DELISTED Orgenesis Inc. Common Stock ORGS	39	-1	-3%	$22.2M
64	GMDA 64 DELISTED Gamida Cell Ltd. Ordinary Shares GMDA	38	+11	+41%	$63.4M
65	65 Imunon IMNN $5.95M	34	-3	-8%	$3.76M
66	66 Adicet Bio ACET $48.1M	32	-21	-40%	$108M
67	67 INmune Bio INMB $45.8M	28	+12	+75%	$10.3M
68	68 Capricor Therapeutics CAPR $423M	25	-8	-24%	$6.64M
69	ONCS 69 DELISTED OncoSec Medical Incorporated ONCS	25	+9	+56%	$3.94M
70	70 DELISTED Scorpius Holdings, Inc. SCPX	24	+9	+60%	$14.1M
71	BLCM 71 DELISTED Bellicum Pharmaceuticals, Inc. BLCM	22	-5	-19%	$6.7M
72	FRLN 72 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	22	+22	–	$155M
73	73 Genprex GNPX $1.88M	22	-7	-24%	$16.8M
74	74 Ocugen OCGN $276M	19	-2	-10%	$4.3M
75	RCOR 75 DELISTED Renovacor, Inc. RCOR	16	+11	+220%	$27.4M